Contrarius Investment Management, an investment management firm, released its third quarter investor letter for the “Contrarius Global Equity Fund.” A copy of the letter can be downloaded here. The fund’s investor class returned 30.9% in the September quarter, compared with 7.3% for the MSCI World benchmark, including net income reinvested, and 5.5% for the Average Global Equity Fund. The fund’s investment philosophy is independent of benchmark considerations, so portfolios typically deviate from the benchmark World Index. Plus, check out the fund’s top five holdings to see your top picks in 2025.
In its Q3 2025 investor letter, Contrarius Global Equity Fund highlighted stocks like Beam Therapeutics Inc. (NASDAQ:BEAM). Beam Therapeutics Inc. (NASDAQ:BEAM) is a biotechnology company focused on the development of precision genetic medicines. Beam Therapeutics Inc. (NASDAQ:BEAM)’s monthly performance was 19.13% and its shares gained 12.26% of its value in the last 52 weeks. On December 29, 2025, Beam Therapeutics Inc. (NASDAQ:BEAM) stock closed at $27.84 per share, with a market capitalization of $2.83 billion.
Contrarius Global Equity Fund stated the following regarding Beam Therapeutics Inc. (NASDAQ:BEAM) in its Q3 2025 investor letter:
“Beam Therapeutics Inc. (NASDAQ:BEAM): Major scientific advances have occurred since CRISPR-Cas9 was first discovered approximately 13 years ago. Beam holds patents for one of those advances, “base edition,” also known as CRISPR 2.0.
Beam Therapeutics Inc. (NASDAQ:BEAM) isn’t on our list of the 30 most popular stocks among hedge funds. According to our database, 27 hedge fund portfolios owned Beam Therapeutics Inc. (NASDAQ:BEAM) at the end of the third quarter, compared to 31 in the previous quarter. While we recognize the potential of Beam Therapeutics Inc. (NASDAQ:BEAM) as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you’re looking for an extremely undervalued AI stock that’s also benefiting significantly from Trump-era tariffs and the offshoring trend, check out our free report on best short-term AI stock.